Table 1 Gender differences at first clinical presentation of PES patients
Total (765) | Male (158) | Female (607) | p value | |
|---|---|---|---|---|
Mean age (years) (Mean ± SD) | 48.4 ± 14.8 | 46.7 ± 17.3 | 48.8 ± 14.1 | 0.110 |
Gender prevalence | – | 158 (20.5) | 607 (79.4) | 0.000 |
Age-wise distribution: | ||||
≤ 29 years | 87 (11.4) | 30 (18.9) | 57 (9.4) | 0.022 |
30-49 years | 303 (39.6) | 56 (35.2) | 247 (40.7) | |
≥ 50 years | 375 (49.0) | 72 (45.3) | 303 (49.) | |
Asymptomatic | 449 (58.6) | 103 (64.8) | 346 (57) | 0.124 |
Incidental finding | 605 (79) | 121 (76.1) | 484 (79.7) | 0.185 |
Seen by endocrinologist | 155 (20.2) | 42 (26.4) | 113 (18.6) | 0.019 |
Common symptoms: | ||||
Headache | 227 (29.6) | 29 (18.3) | 198 (32.6) | 0.001 |
Vision disturbance | 109 (14.2) | 18 (11.3) | 91 (15) | 0.297 |
Fatigue | 33 (4.3) | 7 (4.4) | 26 (4.3) | 0.596 |
Galactorrhea | 6 (0.8) | – | 6 (1.0) | |
Amenorrhea | 5 (0.7) | – | 5 (0.8) | |
Irregular cycle | 11 (1.4) | – | 11 (1.8) | |
Infertility | 10 (1.3) | 6 (3.8) | 4 (0.7) | 0.003 |
Loss of libido | 7 (1.0) | 5 (3.1) | 2 (0.3) | 0.001 |